Liposomal IPC pellets

Liposomal IPC pellets feature nanoscale phospholipid vesicles encapsulating iron polymaltose complex (IPC)n—na ferric hydroxide core stabilized by polymaltose — within a bilayer matrix, yielding spherical multiparticulate aggregates for oral delivery.

This shields iron from gastric degradation and inhibitors, facilitating endocytosis-driven enterocyte absorption and lymphatic transport, achieving 2-4-fold superior bioavailability versus ferrous salts for anemia therapy.

• 2-4x better iron absorption by shielding from GI inhibitors for quick anemia relief.
• Cuts nausea and constipation via non-irritating IPC and liposomal protection.
• Improves oxygen delivery to reduce fatigue in weeks.
• Steady iron supply lowers dosing needs for easy adherence.
• Treats IDA in kids, pregnant women, and CKD patients with minimal side effects.